In this article by 247 BioPharma, Thierry Van Nieuwenhove, the CEO of Quotient Sciences discusses the primary company goals and what steps the Quotient Sciences is taking to meet evolving regulatory requirements.
In addition, Thierry talks about the importance of partnerships and collaborations for the Quotient Sciences growth strategy and what key innovations, or new products will company be showcasing at CPHI Milan this year.
Continue reading the full article or watching the video on 247Bio Pharma.